_id
691487d8ccc777a4e85d9734
Ticker
OMGAQ
Name
OMGAQ
Exchange
PINK
Address
20 Acorn Park Drive, Cambridge, MA, United States, 02140
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://omegatherapeutics.com
Description
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. On February 10, 2025, Omega Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Last Close
0.003
Volume
15000
Current Price
0.003
Change
0
Last Updated
2025-12-26T14:25:49.465Z
Image
-
Ipo Date
-
Market Cap
166098
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-09-30
Revenue
2612000
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
19032000
Operating Income
-16420000
Interest Expense
-
Pretax Income
-16444000
Net Income
-16444000
Eps
-0.2981187967871699
Dividends Per Share
-
Shares Outstanding
55366200
Income Tax Expense
-
EBITDA
-
Operating Margin
-628.6370597243492
Total Other Income Expense Net
-38000
Cash
30377000
Short Term Investments
0
Receivables
0
Inventories
-
Total Current Assets
38953000
Property Plant Equipment
113743000
Total Assets
152727000
Payables
1434000
Short Term Debt
-
Long Term Debt
11587000
Total Liabilities
141184000
Equity
11543000
Depreciation
3099000
Change In Working Capital
-2406000
Cash From Operations
-14015000
Capital Expenditures
16000
Cash From Investing
-
Cash From Financing
-1444000
Net Change In Cash
-15475000
PE
-
PB
0.014335758208438016
ROE
-142.45863293771117
ROA
-10.76692398855474
FCF
-14031000
Fcf Percent
-5.371745788667687
Piotroski FScore
1
Health Score
16
Deep Value Investing Score
5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
1
Value Investing Score
5
Quarters > 0 > quarter
2024-09-30
Quarters > 0 > income Statement > revenue
2612000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
19032000
Quarters > 0 > income Statement > operating Income
-16420000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-16444000
Quarters > 0 > income Statement > net Income
-16444000
Quarters > 0 > income Statement > eps
-0.2981187967871699
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
55159219
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-628.6370597243492
Quarters > 0 > income Statement > total Other Income Expense Net
-38000
Quarters > 0 > balance Sheet > cash
30377000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
0
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
38953000
Quarters > 0 > balance Sheet > property Plant Equipment
113743000
Quarters > 0 > balance Sheet > total Assets
152727000
Quarters > 0 > balance Sheet > payables
1434000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
11587000
Quarters > 0 > balance Sheet > total Liabilities
141184000
Quarters > 0 > balance Sheet > equity
11543000
Quarters > 0 > cash Flow > net Income
-16444000
Quarters > 0 > cash Flow > depreciation
3099000
Quarters > 0 > cash Flow > change In Working Capital
-2406000
Quarters > 0 > cash Flow > cash From Operations
-14015000
Quarters > 0 > cash Flow > capital Expenditures
16000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-1444000
Quarters > 0 > cash Flow > net Change In Cash
-15475000
Quarters > 0 > ratios > PE
-0.2981187967871699
Quarters > 0 > ratios > PB
0.014335758208438016
Quarters > 0 > ratios > ROE
-142.45863293771117
Quarters > 0 > ratios > ROA
-10.76692398855474
Quarters > 0 > ratios > FCF
-14031000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-5.371745788667687
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
2134000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
18714000
Quarters > 1 > income Statement > operating Income
-16580000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-16305000
Quarters > 1 > income Statement > net Income
-16305000
Quarters > 1 > income Statement > eps
-0.2956215109114797
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
55154985
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-776.9447047797564
Quarters > 1 > income Statement > total Other Income Expense Net
-24000
Quarters > 1 > balance Sheet > cash
45852000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
0
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
56063000
Quarters > 1 > balance Sheet > property Plant Equipment
112111000
Quarters > 1 > balance Sheet > total Assets
168225000
Quarters > 1 > balance Sheet > payables
1718000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
12909000
Quarters > 1 > balance Sheet > total Liabilities
141963000
Quarters > 1 > balance Sheet > equity
26262000
Quarters > 1 > cash Flow > net Income
-16305000
Quarters > 1 > cash Flow > depreciation
613000
Quarters > 1 > cash Flow > change In Working Capital
1795000
Quarters > 1 > cash Flow > cash From Operations
-12672000
Quarters > 1 > cash Flow > capital Expenditures
396000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-1113000
Quarters > 1 > cash Flow > net Change In Cash
-14181000
Quarters > 1 > ratios > PE
-0.2956215109114797
Quarters > 1 > ratios > PB
0.00630054660726525
Quarters > 1 > ratios > ROE
-62.08590358693169
Quarters > 1 > ratios > ROA
-9.692376281765492
Quarters > 1 > ratios > FCF
-13068000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-6.123711340206185
Quarters > 1 > health Score
16
Quarters > 2 > quarter
2024-03-31
Quarters > 2 > income Statement > revenue
2360000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
22811000
Quarters > 2 > income Statement > operating Income
-20451000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-20129000
Quarters > 2 > income Statement > net Income
-20129000
Quarters > 2 > income Statement > eps
-0.36495341264257436
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
55154985
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-866.5677966101695
Quarters > 2 > income Statement > total Other Income Expense Net
-9000
Quarters > 2 > balance Sheet > cash
60033000
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
0
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
70890000
Quarters > 2 > balance Sheet > property Plant Equipment
112375000
Quarters > 2 > balance Sheet > total Assets
183680000
Quarters > 2 > balance Sheet > payables
1579000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
13897000
Quarters > 2 > balance Sheet > total Liabilities
142326000
Quarters > 2 > balance Sheet > equity
41354000
Quarters > 2 > cash Flow > net Income
-20129000
Quarters > 2 > cash Flow > depreciation
1816000
Quarters > 2 > cash Flow > change In Working Capital
3065000
Quarters > 2 > cash Flow > cash From Operations
-11805000
Quarters > 2 > cash Flow > capital Expenditures
535000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-1070000
Quarters > 2 > cash Flow > net Change In Cash
-8410000
Quarters > 2 > ratios > PE
-0.36495341264257436
Quarters > 2 > ratios > PB
0.00400118380325966
Quarters > 2 > ratios > ROE
-48.67485612032693
Quarters > 2 > ratios > ROA
-10.958732578397212
Quarters > 2 > ratios > FCF
-12340000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-5.228813559322034
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
989000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
21688000
Quarters > 3 > income Statement > operating Income
-20699000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-20214000
Quarters > 3 > income Statement > net Income
-20214000
Quarters > 3 > income Statement > eps
-0.36656100458968327
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
55144982
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-2092.9221435793734
Quarters > 3 > income Statement > total Other Income Expense Net
-2000
Quarters > 3 > balance Sheet > cash
68443000
Quarters > 3 > balance Sheet > short Term Investments
4986000
Quarters > 3 > balance Sheet > receivables
5125000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
89884000
Quarters > 3 > balance Sheet > property Plant Equipment
114047000
Quarters > 3 > balance Sheet > total Assets
204366000
Quarters > 3 > balance Sheet > payables
1620000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
14885000
Quarters > 3 > balance Sheet > total Liabilities
146350000
Quarters > 3 > balance Sheet > equity
58016000
Quarters > 3 > cash Flow > net Income
-20214000
Quarters > 3 > cash Flow > depreciation
1781000
Quarters > 3 > cash Flow > change In Working Capital
-806000
Quarters > 3 > cash Flow > cash From Operations
-17090000
Quarters > 3 > cash Flow > capital Expenditures
1111000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1625000
Quarters > 3 > cash Flow > net Change In Cash
-13325000
Quarters > 3 > ratios > PE
-0.36656100458968327
Quarters > 3 > ratios > PB
0.0028515400234418093
Quarters > 3 > ratios > ROE
-34.84211252068395
Quarters > 3 > ratios > ROA
-9.891077772232173
Quarters > 3 > ratios > FCF
-18201000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-18.40343781597573
Quarters > 3 > health Score
20
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
3094000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
103355000
Annuals > 0 > income Statement > operating Income
-100261000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-97428000
Annuals > 0 > income Statement > net Income
-97428000
Annuals > 0 > income Statement > eps
-1.766760935745704
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
55144982
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-3240.497737556561
Annuals > 0 > income Statement > total Other Income Expense Net
23000
Annuals > 0 > balance Sheet > cash
68443000
Annuals > 0 > balance Sheet > short Term Investments
4986000
Annuals > 0 > balance Sheet > receivables
5125000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
89884000
Annuals > 0 > balance Sheet > property Plant Equipment
114047000
Annuals > 0 > balance Sheet > total Assets
204366000
Annuals > 0 > balance Sheet > payables
1620000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
14885000
Annuals > 0 > balance Sheet > total Liabilities
146350000
Annuals > 0 > balance Sheet > equity
58016000
Annuals > 0 > cash Flow > net Income
-97428000
Annuals > 0 > cash Flow > depreciation
6771000
Annuals > 0 > cash Flow > change In Working Capital
-9366000
Annuals > 0 > cash Flow > cash From Operations
-91510000
Annuals > 0 > cash Flow > capital Expenditures
2869000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
41823000
Annuals > 0 > cash Flow > net Change In Cash
-2172000
Annuals > 0 > ratios > PE
-1.766760935745704
Annuals > 0 > ratios > PB
0.0028515400234418093
Annuals > 0 > ratios > ROE
-167.93298400441256
Annuals > 0 > ratios > ROA
-47.6732920348786
Annuals > 0 > ratios > FCF
-94379000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-30.50387847446671
Annuals > 0 > health Score
19
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
2073000
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
104839000
Annuals > 1 > income Statement > operating Income
-102766000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-102701000
Annuals > 1 > income Statement > net Income
-102701000
Annuals > 1 > income Statement > eps
-2.13637659122363
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
48072517
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-4957.356488181379
Annuals > 1 > income Statement > total Other Income Expense Net
-157000
Annuals > 1 > balance Sheet > cash
70615000
Annuals > 1 > balance Sheet > short Term Investments
54063000
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
137590000
Annuals > 1 > balance Sheet > property Plant Equipment
7863000
Annuals > 1 > balance Sheet > total Assets
145998000
Annuals > 1 > balance Sheet > payables
3107000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
16603000
Annuals > 1 > balance Sheet > total Liabilities
40027000
Annuals > 1 > balance Sheet > equity
105971000
Annuals > 1 > cash Flow > net Income
-102701000
Annuals > 1 > cash Flow > depreciation
5190000
Annuals > 1 > cash Flow > change In Working Capital
-9882000
Annuals > 1 > cash Flow > cash From Operations
-98515000
Annuals > 1 > cash Flow > capital Expenditures
1380000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
708000
Annuals > 1 > cash Flow > net Change In Cash
-115867000
Annuals > 1 > ratios > PE
-2.13637659122363
Annuals > 1 > ratios > PB
0.0013609152598352378
Annuals > 1 > ratios > ROE
-96.9142501250342
Annuals > 1 > ratios > ROA
-70.34411430293565
Annuals > 1 > ratios > FCF
-99895000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-48.1886155330439
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
144000
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
66176000
Annuals > 2 > income Statement > operating Income
-66032000
Annuals > 2 > income Statement > interest Expense
910000
Annuals > 2 > income Statement > pretax Income
-68280000
Annuals > 2 > income Statement > net Income
-68280000
Annuals > 2 > income Statement > eps
-1.4286470814662982
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
47793469
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-45855.555555555555
Annuals > 2 > income Statement > total Other Income Expense Net
-1338000
Annuals > 2 > balance Sheet > cash
186482000
Annuals > 2 > balance Sheet > short Term Investments
38845000
Annuals > 2 > balance Sheet > receivables
257000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
229286000
Annuals > 2 > balance Sheet > property Plant Equipment
3605000
Annuals > 2 > balance Sheet > total Assets
233333000
Annuals > 2 > balance Sheet > payables
2109000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
19869000
Annuals > 2 > balance Sheet > total Liabilities
32705000
Annuals > 2 > balance Sheet > equity
200628000
Annuals > 2 > cash Flow > net Income
-68280000
Annuals > 2 > cash Flow > depreciation
1387000
Annuals > 2 > cash Flow > change In Working Capital
4662000
Annuals > 2 > cash Flow > cash From Operations
-57609000
Annuals > 2 > cash Flow > capital Expenditures
1467000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
261539000
Annuals > 2 > cash Flow > net Change In Cash
163531000
Annuals > 2 > ratios > PE
-1.4286470814662982
Annuals > 2 > ratios > PB
0.0007146580088522042
Annuals > 2 > ratios > ROE
-34.03313595310724
Annuals > 2 > ratios > ROA
-29.262898946998494
Annuals > 2 > ratios > FCF
-59076000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-410.25
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
28645000
Annuals > 3 > income Statement > operating Income
-28645000
Annuals > 3 > income Statement > interest Expense
777000
Annuals > 3 > income Statement > pretax Income
-29447000
Annuals > 3 > income Statement > net Income
-29447000
Annuals > 3 > income Statement > eps
-0.6302090101547395
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
46725768
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-25000
Annuals > 3 > balance Sheet > cash
22951000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
24003000
Annuals > 3 > balance Sheet > property Plant Equipment
3482000
Annuals > 3 > balance Sheet > total Assets
28083000
Annuals > 3 > balance Sheet > payables
1063000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
8732000
Annuals > 3 > balance Sheet > total Liabilities
92711000
Annuals > 3 > balance Sheet > equity
-64628000
Annuals > 3 > cash Flow > net Income
-29447000
Annuals > 3 > cash Flow > depreciation
1146000
Annuals > 3 > cash Flow > change In Working Capital
1565000
Annuals > 3 > cash Flow > cash From Operations
-26133000
Annuals > 3 > cash Flow > capital Expenditures
1808000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
48618000
Annuals > 3 > cash Flow > net Change In Cash
20677000
Annuals > 3 > ratios > PE
-0.6302090101547395
Annuals > 3 > ratios > PB
-0.0021689871882156343
Annuals > 3 > ratios > ROE
45.56384229745621
Annuals > 3 > ratios > ROA
-104.85703094398747
Annuals > 3 > ratios > FCF
-27941000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.2981187967871699
Valuation > metrics > PB
0.014335758208438016
Valuation > final Score
70
Valuation > verdict
98.6% Undervalued
Profitability > metrics > ROE
-142.45863293771117
Profitability > metrics > ROA
-42.21497702359254
Profitability > metrics > Net Margin
-6.295558958652373
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
12.23113575327038
Risk > metrics > Interest Coverage
-432.10526315789474
Risk > final Score
-1722
Risk > verdict
High
Liquidity > metrics > Current Ratio
27.163877266387725
Liquidity > metrics > Quick Ratio
27.163877266387725
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-2757
Prev Risks > 1
-9083
Prev Risks > 2
-41380
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:20:38.928Z
Earnings History > 0 > period
2024-09-30
Earnings History > 0 > report Date
2024-11-14
Earnings History > 0 > date
2024-09-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.3
Earnings History > 0 > eps Estimate
-0.27
Earnings History > 0 > eps Difference
-0.03
Earnings History > 0 > surprise Percent
-11.1111
Earnings History > 1 > period
2024-06-30
Earnings History > 1 > report Date
2024-08-06
Earnings History > 1 > date
2024-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.3
Earnings History > 1 > eps Estimate
-0.36
Earnings History > 1 > eps Difference
0.06
Earnings History > 1 > surprise Percent
16.6667
Earnings History > 2 > period
2024-03-31
Earnings History > 2 > report Date
2024-05-06
Earnings History > 2 > date
2024-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.36
Earnings History > 2 > eps Estimate
-0.3267
Earnings History > 2 > eps Difference
-0.0333
Earnings History > 2 > surprise Percent
-10.1928
Earnings History > 3 > period
2023-12-31
Earnings History > 3 > report Date
2024-03-28
Earnings History > 3 > date
2023-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.37
Earnings History > 3 > eps Estimate
-0.4325
Earnings History > 3 > eps Difference
0.0625
Earnings History > 3 > surprise Percent
14.4509
Earnings History > 4 > period
2023-09-30
Earnings History > 4 > report Date
2023-11-09
Earnings History > 4 > date
2023-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.4035
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-06-30
Earnings History > 5 > report Date
2023-08-04
Earnings History > 5 > date
2023-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.5391
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-03-31
Earnings History > 6 > report Date
2023-05-04
Earnings History > 6 > date
2023-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.4993
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-12-31
Earnings History > 7 > report Date
2023-03-01
Earnings History > 7 > date
2022-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.6436
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-09-30
Earnings History > 8 > report Date
2022-11-08
Earnings History > 8 > date
2022-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.5391
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-06-30
Earnings History > 9 > report Date
2022-08-04
Earnings History > 9 > date
2022-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.5415
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-03-31
Earnings History > 10 > report Date
2022-05-05
Earnings History > 10 > date
2022-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.4218
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2021-12-31
Earnings History > 11 > report Date
2022-03-10
Earnings History > 11 > date
2021-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.4363
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2021-09-30
Earnings History > 12 > report Date
2021-11-10
Earnings History > 12 > date
2021-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.3879
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-06-30
Earnings History > 13 > report Date
2021-09-10
Earnings History > 13 > date
2021-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.3227
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. On February 10, 2025, Omega Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 4
(Last Updated 2024-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of OMGAQ
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-09-30
EPS Actual
-0.3
EPS Estimate
-0.27
EPS Difference
-0.03
Surprise Percent
-11.1111%
(Last Updated 2024-09-30)
(Last Updated 2024-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.